Clinical Trial: Cryptococcal Optimal ART Timing Trial

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis

Brief Summary: The Cryptococcal Optimal ART Timing (COAT) trial seeks to determine after cryptococcal meningitis (CM) whether early initiation of antiretroviral therapy (ART) prior to hospital discharge results in superior survival compared to standard initiation of ART started as an outpatient.